Financial reports
10-K
2023 FY
Annual report
21 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
27 Apr 23
10-K
2022 FY
Annual report
22 Feb 23
10-Q
2022 Q3
Quarterly report
1 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
29 Apr 22
10-K
2021 FY
Annual report
23 Feb 22
10-Q
2021 Q3
Quarterly report
27 Oct 21
Current reports
8-K
Other Events
9 Feb 24
8-K
Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance
6 Feb 24
8-K
Lilly Reports Third-Quarter 2023 Financial Results, Highlights Strong Sales Growth and Business Development Activity
2 Nov 23
8-K
Lilly Reports Second-Quarter 2023 Financial Results, Highlights Accelerating Revenue Growth and Key Pipeline Advancements
8 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
4 May 23
8-K
Results of Operations and Financial Condition
27 Apr 23
8-K
Departure of Directors or Certain Officers
17 Mar 23
8-K
Other Events
24 Feb 23
8-K
Lilly Reports Fourth-Quarter 2022 Financial Results, Core Business Growth and Pipeline Advancements Support Strong Long-Term Outlook
2 Feb 23
8-K
Lilly Announces 2023 Financial Guidance, Plans to Launch up to Four New Medicines
13 Dec 22
Registration and prospectus
424B2
Prospectus for primary offering
8 Feb 24
FWP
Free writing prospectus
7 Feb 24
424B2
Prospectus for primary offering
7 Feb 24
SC TO-T/A
Third party tender offer statement (amended)
22 Dec 23
SC TO-T/A
Third party tender offer statement (amended)
18 Dec 23
SC TO-T/A
Third party tender offer statement (amended)
4 Dec 23
SC TO-T/A
Third party tender offer statement (amended)
17 Nov 23
SC TO-T/A
Third party tender offer statement (amended)
15 Nov 23
SC TO-T/A
Third party tender offer statement (amended)
8 Nov 23
SC TO-T/A
Third party tender offer statement (amended)
27 Oct 23
Proxies
PX14A6G
Letter to shareholders
27 Mar 24
DEFA14A
Additional proxy soliciting materials
22 Mar 24
DEF 14A
Definitive proxy
22 Mar 24
PRE 14A
Preliminary proxy
8 Mar 24
PX14A6G
Letter to shareholders
21 Apr 23
PX14A6G
Letter to shareholders
10 Apr 23
PX14A6G
Letter to shareholders
4 Apr 23
PX14A6G
Letter to shareholders
24 Mar 23
PX14A6G
Letter to shareholders
22 Mar 23
DEFA14A
Additional proxy soliciting materials
17 Mar 23
Other
UPLOAD
Letter from SEC
15 Nov 23
CORRESP
Correspondence with SEC
9 Nov 23
UPLOAD
Letter from SEC
1 Nov 23
CORRESP
Correspondence with SEC
26 Oct 23
CORRESP
Correspondence with SEC
5 Oct 23
UPLOAD
Letter from SEC
29 Sep 23
CORRESP
Correspondence with SEC
20 Sep 23
UPLOAD
Letter from SEC
6 Sep 23
SD
Conflict minerals disclosure
5 May 23
SD
Conflict minerals disclosure
6 May 22
Ownership
4
Gabrielle Sulzberger
19 Mar 24
4
JUAN R LUCIANO
19 Mar 24
4
KIMBERLY H JOHNSON
19 Mar 24
4
Mary Lynne Hedley
19 Mar 24
4
Ralph Alvarez
19 Mar 24
4
Donald A Zakrowski
11 Mar 24
144
Notice of proposed sale of securities
11 Mar 24
4
Gabrielle Sulzberger
21 Feb 24
4
Mary Lynne Hedley
21 Feb 24
4
JUAN R LUCIANO
21 Feb 24